ICU Medical, Inc. (ICUI) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

22/25

Growth 5 Margin 4 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

22
ICUI Q2 2026: EBITDA Guidance Raised $15M as Margin Expansion and System Growth Offset Tariff Drag
August 07, 2026
22
ICU Medical (ICUI) Q1 2026: Infusion Systems Revenue Hits Record as Gross Margin Expands to 41%
May 08, 2026
18
ICUI Q4 2025: $25M EBITDA Drag from JV and Tariffs Delays Margin Target, but Core Growth Holds
February 23, 2026
23
ICU Medical (ICUI) Q3 2025: Gross Margin Rises to 41% as Portfolio Optimization and Tariff Headwinds Shape Outlook
November 07, 2025
18
ICU Medical (ICUI) Q2 2025: Tariff Expense Climbs to $30M, Margin Expansion Offset by Cost Headwinds
August 08, 2025
22
ICUI Q1 2025: $99M EBITDA Expansion Highlights Margin Resilience Amid $30M Tariff Headwind
July 05, 2025
ICU Medical (ICUI) Q4 2024: 9% Constant Currency Growth Fueled by IV Solutions Shortage and Operational Progress
February 27, 2025

Browse all companies